Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 19, Number 8—August 2013

Research

Duration of Immunity to Norovirus Gastroenteritis

Kirsten Simmons, Manoj Gambhir, Juan Leon, and Ben LopmanComments to Author 
Author affiliations: Rollins School of Public Health, Emory University, Atlanta, Georgia, USA (K. Simmons, J. Leon, B. Lopman); Centers for Disease Control and Prevention, Atlanta (K. Simmons, B. Lopman); Imperial College London, London, UK (M. Gambhir)

Main Article

Figure 2

Age-specific annual incidence of norovirus gastroenteritis, observed (black) and model predicted (red). These results are for model B (which includes presymptomatic and postsymptomatic infectiousness).

Figure 2. . . Age-specific annual incidence of norovirus gastroenteritis, observed (black) and model predicted (red). These results are for model B (which includes presymptomatic and postsymptomatic infectiousness).

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

20th Anniversary - National Infant Immunization Week - Immunization. Power to Protect.

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO